BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10465664)

  • 1. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer.
    Harris RE; Robertson FM; Abou-Issa HM; Farrar WB; Brueggemeier R
    Med Hypotheses; 1999 Apr; 52(4):291-2. PubMed ID: 10465664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
    Richards JA; Petrel TA; Brueggemeier RW
    J Steroid Biochem Mol Biol; 2002 Feb; 80(2):203-12. PubMed ID: 11897504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
    Prosperi JR; Robertson FM
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
    Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
    Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-gamma and interleukin 4 inhibit interleukin 1beta-induced delayed prostaglandin E(2)generation through suppression of cyclooxygenase-2 expression in human fibroblasts.
    Hayashi Y; Kobayashi M; Kuwata H; Atsumi G; Deguchi K; Feng Wei X; Kudo I; Hasegawa K
    Cytokine; 2000 Jun; 12(6):603-12. PubMed ID: 10843735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 upregulation as a perigenetic change in carcinogenesis.
    Tsuji S; Tsujii M; Kawano S; Hori M
    J Exp Clin Cancer Res; 2001 Mar; 20(1):117-29. PubMed ID: 11370818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells.
    Li M; Song S; Lippman SM; Zhang XK; Liu X; Lotan R; Xu XC
    Oncogene; 2002 Jan; 21(3):411-8. PubMed ID: 11821953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cyclooxygenase-2 gene expression in retinal pigment epithelium cells by photoreceptor rod outer segment phagocytosis and growth factors.
    Ershov AV; Bazan NG
    J Neurosci Res; 1999 Oct; 58(2):254-61. PubMed ID: 10502281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens.
    Brueggemeier RW; Quinn AL; Parrett ML; Joarder FS; Harris RE; Robertson FM
    Cancer Lett; 1999 Jun; 140(1-2):27-35. PubMed ID: 10403538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
    Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
    Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis.
    Fosslien E
    Ann Clin Lab Sci; 2001 Oct; 31(4):325-48. PubMed ID: 11688844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant inhibition by the flavonoid antioxidant silymarin against 12-O-tetradecanoylphorbol 13-acetate-caused modulation of antioxidant and inflammatory enzymes, and cyclooxygenase 2 and interleukin-1alpha expression in SENCAR mouse epidermis: implications in the prevention of stage I tumor promotion.
    Zhao J; Sharma Y; Agarwal R
    Mol Carcinog; 1999 Dec; 26(4):321-33. PubMed ID: 10569809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational studies on aromatase, cyclooxygenases, and enzyme inhibitors in breast cancer.
    Brueggemeier RW; Díaz-Cruz ES; Li PK; Sugimoto Y; Lin YC; Shapiro CL
    J Steroid Biochem Mol Biol; 2005 May; 95(1-5):129-36. PubMed ID: 15964185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
    Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
    Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention.
    Chun KS; Surh YJ
    Biochem Pharmacol; 2004 Sep; 68(6):1089-100. PubMed ID: 15313405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
    Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic significance of cyclooxygenase-2 mRNA expression in human breast carcinoma].
    Pang D; Zhao X; Xue Y
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):567-9. PubMed ID: 12667327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages.
    Hinz B; Brune K; Pahl A
    Biochem Biophys Res Commun; 2000 Jun; 272(3):744-8. PubMed ID: 10860826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer.
    Salhab M; Singh-Ranger G; Mokbel R; Jouhra F; Jiang WG; Mokbel K
    J Surg Oncol; 2007 Oct; 96(5):424-8. PubMed ID: 17657731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.